HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation: An Update
Files
Publication date
2025-09-15
Authors
Charpentier, Charlotte
Berzow, Dirk
Le Hingrat, Quentin
Kaiser, Rolf
Gomes, Perpetua
Miranda, Ana Claudia
Damond, Florence
Ghosn, Jade
van Kampen, Jeroen J A
Jensen, Björn-Erik Ole
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
taverne
Abstract
Human immunodeficiency virus type 2 (HIV-2) is an attenuated retroviral infection characterized by specific natural susceptibility to antiretroviral drugs and acquired resistance profiles. Based on the latest knowledge of phenotypic data and clinical follow-up, HIV-2 resistance interpretation rules have been updated and implemented in a freely available resistance analysis tool.
Keywords
HIV-2, Internet tool, drug-resistance rules, update, Taverne, Microbiology (medical), Infectious Diseases
Citation
Charpentier, C, Berzow, D, Le Hingrat, Q, Kaiser, R, Gomes, P, Miranda, A C, Damond, F, Ghosn, J, van Kampen, J J A, Jensen, B-E O, Böhm, M, Wensing, A M J, Descamps, D & Obermeier, M 2025, 'HIV-2 EU—Supporting Standardized HIV-2 Drug Resistance Interpretation : An Update', Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, vol. 81, no. 3, pp. 539-542. https://doi.org/10.1093/cid/ciaf110